The Second Hospital of Dalian Medical University
If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\] The purpose of the clinical trial is to find a treatment for stroke patients with cognitive impairment, and the main questions it aims to answer are: * \[Search for effective treatments of cognitive impairment after stroke\] * \[Explore brain network features with functional near-infrared spectroscopy\] Participants will receive conventional treatment, tDCS treatment, or rTMS treatment, or tDCS-rTMS treatment. And then compare cognitive function and brain function.
• Meet the clinical diagnostic criteria of the Expert Consensus on the Management of Cognitive Impairment after Stroke in 2021;
• 30-80 years old, right-handed, unilateral hemiplegia;
• Verbal expression can cooperate with the completion of the evaluation, sustained attention time is longer than 5 minutes;
• Simple Mental State Examination Scale (MMSE) score ≤26 points; MoCA scale score \< 26 points; Memory test (RMBT) score less than 21 points;
• patients or their family agree to sign the informed consent;
• The Ethics Committee approved the trial.